Cytokinetics Announces Initiation of Phase 1 Clinical Study of AMG 594, a Cardiac Troponin Activator Biotech Investing
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock Biotech Investing
Cerecor Receives Fast Track Designation from FDA for CERC-801 for the Treatment of PGM1 Deficiency Biotech Investing
Assertio Therapeutics Announces FDA Notification of Acceptance for Filing of 505(b)(2) NDA for Long-acting Cosyntropin Pharmaceutical Investing
Biocure Technology Corp Announces a MOU with the Government of Uzbekistan and Gold-Dream LLC to Build a Manufacturing Plant to Produce Biosimilars Biotech Investing
BriaCell to Present Clinical and Scientific Findings with New Insights at Key Oncology Conferences Biotech Investing
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart
